Investor Relations

Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Evolent Health, Inc. (Arlington, VA)
Event Date 3/27/2017
Filing Date 3/31/2017

Abstract: Registrant reported that on March 27, it entered into an underwriting agreement for the sale of 7.5 million of its class A common stock. The underwriting agreement, and the opinion and the consent of Cravath Swaine & Moore LLP were included by exhibit.

File Section(s)

  1. FORM 8-K
  2. EX-1.1
  3. EX-5.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.